The CD Laboratory for
Immunomodulation aims at the development of novel therapeutic approaches
for Type I allergy based on the modulation of the disease-eliciting
allergen-specific T cell response.
The
CD Laboratory for Immunomodulation has been
implemented in January 2008 at the Department of
Pathophysiology and Allergy Research (Module 1-3) and the
Institute of Immunology (Module 4),
Center for Pathophysiology, Infectiology &
Immunology of the Medical
University of Vienna.